|
|
Exchange: |
N/A |
Security
Type: |
N/A |
Shares
Out: |
207,851,000 |
Market
Cap: |
11.18(B) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$32.18 - $59.82 |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Catalent is a holding company. Through its subsidiaries, Co. has two operating and reporting segments: Biologics and Pharma and Consumer Health. The Biologics segment provides development and manufacturing for biologic proteins; cell, gene, and other nucleic acid therapies; plasmid DNA; induced pluripotent stem cells; and vaccines. The Pharma and Consumer Health segment comprises Co.'s capabilities for oral solids, softgel formulations, Zydis® fast-dissolve technologies, and gummy, soft chew, and lozenge dosage forms; formulation, development, and manufacturing platforms for oral, nasal, inhaled, and topical dose forms; and clinical trial development and supply services.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
1,000 |
1,000 |
Total Buy Value |
$0 |
$0 |
$49,980 |
$49,980 |
Total People Bought |
0 |
0 |
1 |
1 |
Total Buy Transactions |
0 |
0 |
1 |
1 |
Total Shares Sold |
387 |
387 |
11,063 |
116,582 |
Total Sell Value |
$21,749 |
$21,749 |
$512,581 |
$11,151,362 |
Total People Sold |
1 |
1 |
12 |
18 |
Total Sell Transactions |
1 |
1 |
25 |
69 |
End Date |
2024-03-03 |
2023-12-01 |
2023-06-02 |
2022-06-02 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Gennadios Aristippos |
President, Softgel Tech. |
|
2018-07-23 |
4 |
A |
$0.00 |
$0 |
D/D |
2,052 |
24,577 |
|
- |
|
Miyamoto Lance |
SVP, Human Resources |
|
2018-07-23 |
4 |
A |
$0.00 |
$0 |
D/D |
2,621 |
43,702 |
|
- |
|
Maselli Alessandro |
SVP, Global Operations |
|
2018-07-23 |
4 |
A |
$0.00 |
$0 |
D/D |
2,052 |
15,655 |
|
- |
|
Chiminski John R |
Chair, President & CEO |
|
2018-07-23 |
4 |
A |
$0.00 |
$0 |
D/D |
27,006 |
257,087 |
|
- |
|
Fasman Steven L |
SVP & General Counsel |
|
2018-06-20 |
4 |
AS |
$41.78 |
$94,089 |
D/D |
(2,252) |
43,316 |
|
- |
|
Fasman Steven L |
SVP & General Counsel |
|
2018-06-20 |
4 |
D |
$41.78 |
$457,658 |
D/D |
(10,954) |
45,568 |
|
- |
|
Fasman Steven L |
SVP & General Counsel |
|
2018-06-20 |
4 |
OE |
$24.26 |
$375,011 |
D/D |
15,458 |
56,522 |
|
- |
|
Downie William |
SVP, Global Sales & Marketing |
|
2018-03-08 |
4 |
S |
$41.80 |
$379,628 |
D/D |
(9,082) |
35,393 |
|
- |
|
Downie William |
SVP, Global Sales & Marketing |
|
2018-03-08 |
4 |
D |
$40.95 |
$530,917 |
D/D |
(12,965) |
44,475 |
|
- |
|
Downie William |
SVP, Global Sales & Marketing |
|
2018-03-08 |
4 |
OE |
$20.50 |
$405,239 |
D/D |
15,515 |
48,019 |
|
- |
|
Joseph Wetteny |
SVP & Chief Financial Officer |
|
2018-02-06 |
4 |
A |
$0.00 |
$0 |
D/D |
11,974 |
26,251 |
|
- |
|
Chiminski John R |
Chair, President & CEO |
|
2017-12-12 |
4 |
AS |
$39.51 |
$3,089,287 |
D/D |
(78,190) |
230,081 |
|
- |
|
Chiminski John R |
Chair, President & CEO |
|
2017-12-11 |
4 |
AS |
$39.70 |
$4,099,740 |
D/D |
(103,268) |
308,271 |
|
- |
|
Chiminski John R |
Chair, President & CEO |
|
2017-12-11 |
4 |
D |
$39.70 |
$4,971,512 |
D/D |
(125,227) |
411,539 |
|
- |
|
Chiminski John R |
Chair, President & CEO |
|
2017-12-11 |
4 |
OE |
$10.71 |
$2,213,596 |
D/D |
206,685 |
536,766 |
|
- |
|
Roehrhoff Uwe |
Director |
|
2017-11-21 |
4 |
B |
$39.22 |
$294,150 |
D/D |
7,500 |
16,489 |
2.39 |
- |
|
Fasman Steven L |
SVP & General Counsel |
|
2017-11-10 |
4 |
A |
$0.00 |
$0 |
D/D |
5,000 |
41,064 |
|
- |
|
Fasman Steven L |
SVP & General Counsel |
|
2017-10-23 |
4 |
D |
$42.74 |
$68,469 |
D/D |
(1,602) |
36,064 |
|
- |
|
Chiminski John R |
Chair, President & CEO |
|
2017-10-23 |
4 |
D |
$42.74 |
$154,035 |
D/D |
(3,604) |
330,081 |
|
- |
|
Chiminski John R |
Chair, President & CEO |
|
2017-09-16 |
4 |
D |
$39.49 |
$870,320 |
D/D |
(22,039) |
333,685 |
|
- |
|
Miyamoto Lance |
SVP - Human Resources |
|
2017-08-29 |
4 |
AS |
$38.22 |
$325,329 |
D/D |
(8,512) |
41,081 |
|
- |
|
Miyamoto Lance |
SVP - Human Resources |
|
2017-08-29 |
4 |
D |
$38.22 |
$892,131 |
D/D |
(23,342) |
49,593 |
|
- |
|
Miyamoto Lance |
SVP - Human Resources |
|
2017-08-29 |
4 |
OE |
$12.14 |
$475,135 |
D/D |
39,138 |
57,293 |
|
- |
|
Dolan Christine |
SVP - Product Development |
|
2017-08-29 |
4 |
AS |
$38.75 |
$61,768 |
D/D |
(1,594) |
19,449 |
|
- |
|
Dolan Christine |
SVP - Product Development |
|
2017-08-29 |
4 |
D |
$38.75 |
$231,105 |
D/D |
(5,964) |
21,043 |
|
- |
|
821 Records found
|
|
Page 25 of 33 |
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Acquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|